Latest On Aquestive Therapeutics, Inc (AQST):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-31 16:49 EST | News | Aquestive Therapeutics releases positive clinical data on anaphylm for anaphylaxis treatment | N/A |  |
| 2023-05-03 20:59 EST | News | Aquestive Therapeutics, Inc. (AQST) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-02 19:43 EST | News | Aquestive Therapeutics reports Q1 results, raises FY 2023 revenue guidance | N/A | |
| 2023-05-01 19:11 EST | News | Aquestive Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-04-20 18:42 EST | News | Aquestive receives conditional FDA approval for proprietary name Anaphylm for lead candidate AQST-109 | N/A | |
| 2023-03-30 00:48 EST | News | Aquestive, Pharmanovia add territories to market seizure drug Libervant | N/A | |
| 2023-03-09 13:04 EST | News | Aquestive upgraded at Wedbush after Q4 cash update | N/A | |
| 2023-03-08 22:19 EST | News | Aquestive Therapeutics, Inc. (AQST) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-08 06:33 EST | News | Aquestive Therapeutics GAAP EPS of -$0.23 in-line, revenue of $10.68M beats by $0.26M | N/A | |
| 2023-03-07 01:15 EST | News | Aquestive Therapeutics FY 2022 Earnings Preview | N/A | |
| 2022-11-29 20:46 EST | News | Aquestive Therapeutics: Going All-In On AQST-109 | N/A | |
| 2022-11-02 13:25 EST | News | Aquestive Therapeutics, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-02 13:25 EST | News | Aquestive Therapeutics, Inc. (AQST) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 22:23 EST | News | Aquestive Therapeutics GAAP EPS of -$0.23 beats by $0.07, revenue of $11.46M beats by $0.42M | N/A | |
| 2022-10-27 21:41 EST | News | Aquestive out licenses anti-seizure therapy to Assertio unit | N/A | |
| 2022-10-11 12:20 EST | News | Aquestive Therapeutics receives positive FDA response for AQST-109 epinephrine for severe allergic reaction | N/A | |
| 2022-09-28 15:09 EST | News | Aquestive Therapeutics, Pharmanovia ink licensing & supply pact for Libervant buccal film | N/A | |
| 2022-09-27 23:50 EST | News | Aquestive adds 20% as epinephrine sublingual film outperforms autoinjector | N/A | |
| 2022-09-05 13:08 EST | News | Aquestive Therapeutics: FDA Stymies Libervant Launch | N/A | |
| 2022-09-03 05:21 EST | News | Aquestive Therapeutics: Waiting To Buy After FDA Goes Halfway With Libervant | N/A | |
| 2022-08-31 09:24 EST | News | Aquestive wins FDA tentative approval for ant-seizure medication | N/A | |
| 2022-08-29 08:49 EST | News | Aquestive Therapeutics: A First Take | N/A | |
| 2022-08-03 17:17 EST | News | Shares of Aquestive Therapeutics fall after Q2 revenue decreases, loss widens | N/A | |
| 2022-08-03 17:16 EST | News | Aquestive Therapeutics, Inc. (AQST) CEO Dan Barber on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-03 02:59 EST | News | Aquestive Therapeutics GAAP EPS of -$0.36 in-line, revenue of $13.27M beats by $2.7M | N/A | |
| 2022-08-01 22:03 EST | News | Aquestive Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-06-20 08:15 EST | News | Aquestive Therapeutics (AQST) Investor Presentation - Slideshow | N/A | |
| 2022-06-15 22:10 EST | News | Aquestive surges 31% after topline data for oral epinephrine candidate | N/A | |
| 2022-06-06 16:29 EST | News | Aquestive Therapeutics to raise $8.5M in equity offering | N/A | |
| 2022-05-27 00:36 EST | News | Aquestive Therapeutics: Sell-Off Prompts A Change In Tactics | N/A | |
| 2022-05-18 02:52 EST | News | Aquestive Therapeutics CEO Keith Kendall to resign | N/A | |
| 2022-05-04 22:44 EST | News | Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 03:15 EST | News | Aquestive Therapeutics GAAP EPS of -$0.32 beats by $0.09, revenue of $12.27M beats by $2.15M | N/A | |
| 2022-05-03 09:20 EST | News | Aquestive Therapeutics Q1 2022 Earnings Preview | N/A | |
| 2022-04-12 23:33 EST | News | Aquestive stock falls 7% amid data from study of oral film AQST-109 for allergies | N/A | |
| 2022-03-18 11:46 EST | News | Aquestive Therapeutics nabs Fast Track designation for allergic reaction product | N/A | |
| 2022-03-09 19:51 EST | News | Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-09 03:06 EST | News | Aquestive Therapeutics GAAP EPS of -$1.85 misses by $0.36, revenue of $50.83M beats by $1.73M | N/A | |
| 2022-03-08 09:11 EST | News | Aquestive Therapeutics FY 2021 Earnings Preview | N/A | |
| 2022-02-25 22:52 EST | News | Aquestive IND for AQST-109 cleared by FDA to enter trial for allergic reactions | N/A | |
| 2022-02-25 22:51 EST | News | Aquestive posts positive topline study data for epinephrine oral film | N/A | |
| 2022-02-22 18:06 EST | News | Aquestive Therapeutics: Discounted With An Incredible Risk-Reward For 2022 | N/A | |
| 2021-12-21 16:28 EST | News | Aquestive sheds a third after receiving FDA response for Libervant application | N/A | |
| 2021-11-29 23:51 EST | News | Aquestive Therapeutics: Looking To End 2021 On A Bullish Note | N/A | |
| 2021-11-04 03:50 EST | News | Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 07:52 EST | News | Aquestive Therapeutics EPS beats by $0.06, beats on revenue | N/A | |
| 2021-11-02 12:00 EST | News | Aquestive Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-10-25 12:52 EST | News | Aquestive Therapeutics posts topline data from early-stage trial of AQST-109 | N/A | |
| 2021-09-30 09:08 EST | News | IntelGenx and Aquestive ink deal to market Tadalafil oral films in the U.S. | N/A | |
| 2021-08-04 23:37 EST | News | Aquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call Transcript | N/A | |
About Aquestive Therapeutics, Inc (AQST):
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
General
- Name Aquestive Therapeutics, Inc
- Symbol AQST
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 187
- Fiscal Year EndDecember
- IPO Date2018-07-25
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.aquestive.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 3.96
- Enterprise Value Revenue 4.45
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.76
- Next Year EPS Estimate -$1.29
- Next Quarter EPS Estimate -$0.43
- Profit Margin -122%
- Operating Margin -94%
- Return on Assets -38%
- Revenue 45.85 million
- Earnings Per Share -$2.61
- Revenue Per Share $1.36
- Gross Profit 32.89 million
- Quarterly Earnings Growth -56.5%
View More
Highlights
- Market Capitalization 185.42 million
- EBITDA -50208000
- PE Ratio -36.42
- Analyst Target Price $14.67
- Book Value Per Share -$0.99
View More
Share Statistics
- Shares Outstanding 36.21 million
- Shares Float 34.05 million
- % Held by Insiders 685%
- % Held by Institutions 59.46%
- Shares Short 2.63 million
- Shares Short Prior Month 1.25 million
- Short Ratio 2.45
- Short % of Float 13%
- Short % of Shares Outstanding 8%
View More
Technicals
- Beta 3.72
- 52 Week High $9.47
- 52 Week Low $1.75
- 50 Day Moving Average 5.41
- 200 Day Moving Average 6.06
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Aquestive Therapeutics, Inc (AQST) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Aquestive Therapeutics, Inc (AQST) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-09 | $7.15 million | -$0.61 | -$0.28 | -117.86% |
| 2020-09-30 | 2020-11-04 | $N/A | -$0.49 | -$0.43 | -13.43% |
| 2020-06-30 | 2020-08-04 | $N/A | -$0.07 | -$0.44 | 84.21% |
| 2020-03-31 | 2020-05-05 | $8.77 million | -$0.49 | -$0.48 | -2.51% |
| 2019-12-31 | 2020-03-11 | $16.42 million | -$0.48 | -$0.40 | -21.21% |
| 2019-09-30 | 2019-11-05 | $12.42 million | -$0.54 | -$0.72 | 24.48% |
| 2019-06-30 | 2019-08-06 | $11.13 million | -$0.82 | -$0.66 | -24.24% |
| 2019-03-31 | 2019-05-08 | $12.64 million | -$0.59 | -$0.49 | -20.41% |
| 2018-12-31 | 2019-03-14 | $16.82 million | -$0.56 | -$0.56 | -0.9% |
| 2018-09-30 | 2018-11-06 | $13.27 million | -$0.64 | -$0.34 | -90.08% |
| 2018-06-30 | 2018-09-04 | $13.93 million | -$0.47 | -$0.30 | -56.33% |
Aquestive Therapeutics, Inc (AQST) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Aquestive Therapeutics, Inc (AQST) Chart:
Aquestive Therapeutics, Inc (AQST) News:
Below you will find a list of latest news for Aquestive Therapeutics, Inc (AQST) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aquestive Therapeutics, Inc (AQST) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-04-19 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-04-19 | 1 | 0 | CALL | 0 | 0 | 1405.82 | TRUE | 0 | 0 |
| 2024-04-19 | 1.5 | 0 | CALL | 0 | 0 | 671.74 | TRUE | 0 | 0 |
| 2024-04-19 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-04-19 | 2.5 | 1.2 | CALL | 5 | 646 | 405.15 | TRUE | -0.2 | -0.14 |
| 2024-04-19 | 3 | 1.2 | CALL | 0 | 50 | 500.45 | TRUE | 0 | 0 |
| 2024-04-19 | 3.5 | 0.55 | CALL | 2 | 51 | 204.67 | TRUE | 0.55 | 0 |
| 2024-04-19 | 4 | 0.2 | CALL | 56 | 481 | 158.93 | FALSE | -0.01 | -0.05 |
| 2024-04-19 | 4.5 | 0.05 | CALL | 10 | 367 | 149.97 | FALSE | -0.05 | -0.5 |
| 2024-04-19 | 5 | 0.05 | CALL | 19 | 3012 | 219.65 | FALSE | 0 | 0 |
| 2024-04-19 | 5.5 | 0.1 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 7.5 | 0.05 | CALL | 1 | 2077 | 443.36 | FALSE | 0.04 | 4 |
| 2024-04-19 | 10 | 0.01 | CALL | 0 | 729 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 2.5 | 0.04 | PUT | 0 | 473 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 3.5 | 0.1 | PUT | 0 | 231 | 0 | FALSE | 0 | 0 |
| 2024-04-19 | 4 | 0.25 | PUT | 5 | 632 | 153.05 | TRUE | -0.1 | -0.29 |
| 2024-04-19 | 4.5 | 0.65 | PUT | 15 | 95 | 189.87 | TRUE | 0 | 0 |
| 2024-04-19 | 5 | 0.88 | PUT | 0 | 2200 | 356.96 | TRUE | 0 | 0 |
| 2024-04-19 | 5.5 | 1.2 | PUT | 0 | 2 | 855.51 | TRUE | 0 | 0 |
| 2024-04-19 | 7.5 | 3.3 | PUT | 0 | 0 | 1028.26 | TRUE | 0 | 0 |
| 2024-04-19 | 10 | 0 | PUT | 0 | 0 | 1389.23 | TRUE | 0 | 0 |
| 2024-05-17 | 0.5 | 0 | CALL | 0 | 0 | 496.22 | TRUE | 0 | 0 |
| 2024-05-17 | 1 | 0 | CALL | 0 | 0 | 906.39 | TRUE | 0 | 0 |
| 2024-05-17 | 1.5 | 0 | CALL | 0 | 0 | 276.58 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 0 | CALL | 0 | 0 | 168.72 | TRUE | 0 | 0 |
| 2024-05-17 | 2.5 | 1.6 | CALL | 31 | 2202 | 171.34 | TRUE | 0.15 | 0.1 |
| 2024-05-17 | 3 | 1.11 | CALL | 2 | 68 | 123.91 | TRUE | -0.09 | -0.08 |
| 2024-05-17 | 3.5 | 0.85 | CALL | 13 | 58 | 138.81 | TRUE | -0.12 | -0.12 |
| 2024-05-17 | 4 | 0.65 | CALL | 64 | 174 | 146.73 | FALSE | -0.01 | -0.02 |
| 2024-05-17 | 4.5 | 0.45 | CALL | 3 | 119 | 141.38 | FALSE | 0.05 | 0.13 |
| 2024-05-17 | 5 | 0.34 | CALL | 141 | 7388 | 145.8 | FALSE | -0.06 | -0.15 |
| 2024-05-17 | 5.5 | 0.3 | CALL | 0 | 111 | 165.59 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.1 | CALL | 431 | 3024 | 161.21 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.08 | CALL | 2 | 258 | 197.83 | FALSE | 0.03 | 0.6 |
| 2024-05-17 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0.12 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.15 | PUT | 3 | 1274 | 171.92 | FALSE | 0.01 | 0.07 |
| 2024-05-17 | 3 | 0.24 | PUT | 250 | 500 | 151.1 | FALSE | -0.06 | -0.2 |
| 2024-05-17 | 3.5 | 0.4 | PUT | 0 | 45 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 0.73 | PUT | 31 | 78 | 154.97 | TRUE | -0.02 | -0.03 |
| 2024-05-17 | 4.5 | 0 | PUT | 0 | 0 | 137.75 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 1.4 | PUT | 5 | 388 | 150.35 | TRUE | -0.05 | -0.03 |
| 2024-05-17 | 5.5 | 1.85 | PUT | 0 | 1 | 269.39 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 3.5 | PUT | 0 | 20 | 143.13 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 215.89 | TRUE | 0 | 0 |
| 2024-08-16 | 0.5 | 0 | CALL | 0 | 0 | 244.19 | TRUE | 0 | 0 |
| 2024-08-16 | 1 | 0 | CALL | 0 | 0 | 522.68 | TRUE | 0 | 0 |
| 2024-08-16 | 1.5 | 0 | CALL | 0 | 0 | 170.18 | TRUE | 0 | 0 |
| 2024-08-16 | 2 | 0 | CALL | 0 | 0 | 217.55 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 1.55 | CALL | 3 | 425 | 130.61 | TRUE | -0.25 | -0.14 |
| 2024-08-16 | 3 | 1.8 | CALL | 2 | 0 | 163.1 | TRUE | 1.8 | 0 |
| 2024-08-16 | 3.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 4 | 1.15 | CALL | 5 | 7 | 129.01 | FALSE | 1.15 | 0 |
| 2024-08-16 | 4.5 | 1.25 | CALL | 0 | 84 | 210.05 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.85 | CALL | 25 | 2080 | 128.5 | FALSE | -0.1 | -0.11 |
| 2024-08-16 | 5.5 | 0.7 | CALL | 1 | 3 | 124.52 | FALSE | 0.7 | 0 |
| 2024-08-16 | 7.5 | 0.4 | CALL | 7 | 1836 | 145.94 | FALSE | -0.1 | -0.2 |
| 2024-08-16 | 10 | 0.3 | CALL | 1 | 1273 | 138.63 | FALSE | -0.05 | -0.14 |
| 2024-08-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2 | 0.2 | PUT | 0 | 12 | 131.91 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.35 | PUT | 0 | 411 | 132.08 | FALSE | 0 | 0 |
| 2024-08-16 | 3 | 0 | PUT | 0 | 0 | 128.48 | FALSE | 0 | 0 |
| 2024-08-16 | 3.5 | 0 | PUT | 0 | 0 | 120.29 | FALSE | 0 | 0 |
| 2024-08-16 | 4 | 0 | PUT | 0 | 0 | 184.44 | TRUE | 0 | 0 |
| 2024-08-16 | 4.5 | 1.34 | PUT | 0 | 0 | 292.59 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 1.8 | PUT | 55 | 293 | 124.79 | TRUE | -0.15 | -0.08 |
| 2024-08-16 | 5.5 | 0 | PUT | 0 | 0 | 132.43 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 3.9 | PUT | 0 | 60 | 129.56 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 5.4 | PUT | 0 | 1 | 172.69 | TRUE | 0 | 0 |
| 2024-11-15 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-11-15 | 1 | 0 | CALL | 0 | 0 | 177.71 | TRUE | 0 | 0 |
| 2024-11-15 | 1.5 | 0 | CALL | 0 | 0 | 167.42 | TRUE | 0 | 0 |
| 2024-11-15 | 2 | 0 | CALL | 0 | 0 | 224.16 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 2.12 | CALL | 2 | 85 | 133.15 | TRUE | 2.12 | 0 |
| 2024-11-15 | 3 | 1.91 | CALL | 0 | 868 | 258.21 | TRUE | 0 | 0 |
| 2024-11-15 | 3.5 | 1.71 | CALL | 0 | 450 | 253.54 | TRUE | 0 | 0 |
| 2024-11-15 | 4 | 1.7 | CALL | 0 | 265 | 137.77 | FALSE | 0 | 0 |
| 2024-11-15 | 4.5 | 1.69 | CALL | 0 | 165 | 245.9 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 1.4 | CALL | 0 | 393 | 251.76 | FALSE | 0 | 0 |
| 2024-11-15 | 5.5 | 1.3 | CALL | 0 | 100 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 0.85 | CALL | 0 | 1051 | 258.33 | FALSE | 0 | 0 |
| 2024-11-15 | 10 | 0.6 | CALL | 0 | 984 | 128.64 | FALSE | 0 | 0 |
| 2024-11-15 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 1.5 | 0 | PUT | 0 | 0 | 191.88 | FALSE | 0 | 0 |
| 2024-11-15 | 2 | 0.3 | PUT | 0 | 15 | 332.87 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0.5 | PUT | 0 | 153 | 115.18 | FALSE | 0 | 0 |
| 2024-11-15 | 3 | 0.8 | PUT | 0 | 21 | 124.35 | FALSE | 0 | 0 |
| 2024-11-15 | 3.5 | 1.05 | PUT | 0 | 9 | 112.69 | FALSE | 0 | 0 |
| 2024-11-15 | 4 | 0 | PUT | 0 | 0 | 73.85 | TRUE | 0 | 0 |
| 2024-11-15 | 4.5 | 0 | PUT | 0 | 0 | 200.79 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 2 | PUT | 0 | 126 | 183.9 | TRUE | 0 | 0 |
| 2024-11-15 | 5.5 | 0 | PUT | 0 | 0 | 126.66 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 4.1 | PUT | 0 | 225 | 67.94 | TRUE | 0 | 0 |
| 2024-11-15 | 10 | 6.2 | PUT | 0 | 57 | 136.75 | TRUE | 0 | 0 |
Latest AQST Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:01 PM EST | 100 | $0.8297 |
| Jun 13, 2022 7:01 PM EST | 100 | $0.8297 |
| Jun 13, 2022 7:31 PM EST | 100 | $0.8055 |
| Jun 13, 2022 7:34 PM EST | 2 | $0.8055 |
| Jun 13, 2022 7:54 PM EST | 100 | $0.8177 |
Aquestive Therapeutics, Inc (AQST) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm |
| 2019-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1398733/000000000019013614/0000000000-19-013614-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1398733/000089742319000028/0000897423-19-000028-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1398733/000089742320000050/0000897423-20-000050-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1398733/000110465920053373/0001104659-20-053373-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1398733/000110465920053375/0001104659-20-053375-index.htm |
| 2020-06-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1398733/000110465920069816/0001104659-20-069816-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118039945/0001140361-18-039945-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036118041664/0001140361-18-041664-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036118042519/0001140361-18-042519-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036118042522/0001140361-18-042522-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043649/0001140361-18-043649-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/0001140361-18-043653-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043656/0001140361-18-043656-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043665/0001140361-18-043665-index.htm |
| 2018-11-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043897/0001140361-18-043897-index.htm |
| 2018-11-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/0001140361-18-044032-index.htm |
| 2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044399/0001140361-18-044399-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044533/0001140361-18-044533-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044536/0001140361-18-044536-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/0001140361-18-044723-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044868/0001140361-18-044868-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044870/0001140361-18-044870-index.htm |
| 2018-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044886/0001140361-18-044886-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044950/0001140361-18-044950-index.htm |
| 2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036118045429/0001140361-18-045429-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036119000279/0001140361-19-000279-index.htm |
| 2019-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000114036119000283/0001140361-19-000283-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119004909/0001140361-19-004909-index.htm |
| 2019-03-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119004934/0001140361-19-004934-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119008622/0001140361-19-008622-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119008649/0001140361-19-008649-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119011182/0001140361-19-011182-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119012961/0001140361-19-012961-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119014361/0001140361-19-014361-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119014365/0001140361-19-014365-index.htm |
| 2019-09-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1398733/000114036119016535/0001140361-19-016535-index.htm |
| 2019-09-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1398733/000114036119016686/0001140361-19-016686-index.htm |
| 2019-09-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119016847/0001140361-19-016847-index.htm |
| 2019-09-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119016849/0001140361-19-016849-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119017521/0001140361-19-017521-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119018473/0001140361-19-018473-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119019846/0001140361-19-019846-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119019856/0001140361-19-019856-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119020406/0001140361-19-020406-index.htm |
| 2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119021280/0001140361-19-021280-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119021505/0001140361-19-021505-index.htm |
| 2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119021749/0001140361-19-021749-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119022101/0001140361-19-022101-index.htm |
| 2019-12-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119022296/0001140361-19-022296-index.htm |
| 2019-12-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036119022649/0001140361-19-022649-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036119022653/0001140361-19-022653-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120000604/0001140361-20-000604-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120000658/0001140361-20-000658-index.htm |
| 2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120002434/0001140361-20-002434-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120002638/0001140361-20-002638-index.htm |
| 2020-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120005493/0001140361-20-005493-index.htm |
| 2020-03-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1398733/000114036120005499/0001140361-20-005499-index.htm |
| 2020-03-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036120005609/0001140361-20-005609-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120006442/0001140361-20-006442-index.htm |
| 2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120009240/0001140361-20-009240-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120009673/0001140361-20-009673-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120010722/0001140361-20-010722-index.htm |
| 2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036120010724/0001140361-20-010724-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120012242/0001140361-20-012242-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120014126/0001140361-20-014126-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120014990/0001140361-20-014990-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120015330/0001140361-20-015330-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120017448/0001140361-20-017448-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036120017454/0001140361-20-017454-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120017885/0001140361-20-017885-index.htm |
| 2020-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120021614/0001140361-20-021614-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120024385/0001140361-20-024385-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1398733/000114036120024551/0001140361-20-024551-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1398733/000114036120024555/0001140361-20-024555-index.htm |
| 2019-09-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1398733/000117266119001901/0001172661-19-001901-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1398733/000117494719000605/0001174947-19-000605-index.htm |
| 2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1398733/000117494719000606/0001174947-19-000606-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1398733/000119312519041022/0001193125-19-041022-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1398733/000119312520038109/0001193125-20-038109-index.htm |
| 2019-01-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919000168/0001214659-19-000168-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919000170/0001214659-19-000170-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001723/0001214659-19-001723-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001724/0001214659-19-001724-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001748/0001214659-19-001748-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001749/0001214659-19-001749-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001750/0001214659-19-001750-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001751/0001214659-19-001751-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001752/0001214659-19-001752-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001753/0001214659-19-001753-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001754/0001214659-19-001754-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919002418/0001214659-19-002418-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919002419/0001214659-19-002419-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919003383/0001214659-19-003383-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919003979/0001214659-19-003979-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919003980/0001214659-19-003980-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004243/0001214659-19-004243-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004244/0001214659-19-004244-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004245/0001214659-19-004245-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004246/0001214659-19-004246-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004247/0001214659-19-004247-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004250/0001214659-19-004250-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004458/0001214659-19-004458-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004459/0001214659-19-004459-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005182/0001214659-19-005182-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/0001214659-19-005183-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005184/0001214659-19-005184-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005489/0001214659-19-005489-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005618/0001214659-19-005618-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005619/0001214659-19-005619-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005969/0001214659-19-005969-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919006187/0001214659-19-006187-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919006188/0001214659-19-006188-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919007535/0001214659-19-007535-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465919007536/0001214659-19-007536-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920000018/0001214659-20-000018-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920000041/0001214659-20-000041-index.htm |
| 2020-02-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920001859/0001214659-20-001859-index.htm |
| 2020-02-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920001860/0001214659-20-001860-index.htm |
| 2020-02-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920001881/0001214659-20-001881-index.htm |
| 2020-02-26 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920001882/0001214659-20-001882-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002183/0001214659-20-002183-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002184/0001214659-20-002184-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002746/0001214659-20-002746-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/0001214659-20-002747-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002748/0001214659-20-002748-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002749/0001214659-20-002749-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002750/0001214659-20-002750-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002751/0001214659-20-002751-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002752/0001214659-20-002752-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002753/0001214659-20-002753-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002754/0001214659-20-002754-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920003145/0001214659-20-003145-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920003146/0001214659-20-003146-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920003962/0001214659-20-003962-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920004314/0001214659-20-004314-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005338/0001214659-20-005338-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005339/0001214659-20-005339-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005427/0001214659-20-005427-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005755/0001214659-20-005755-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005756/0001214659-20-005756-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005757/0001214659-20-005757-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005758/0001214659-20-005758-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005759/0001214659-20-005759-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005776/0001214659-20-005776-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920006104/0001214659-20-006104-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/0001214659-20-007366-index.htm |
| 2019-09-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1398733/999999999519002118/9999999995-19-002118-index.htm |
Aquestive Therapeutics, Inc (AQST) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aquestive Therapeutics, Inc (AQST). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 685%Institutional Ownership: 5946%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-11-27 | LORI J BRAENDER | General Counsel | Buy | 1,000.00 | 10.57 | 10,570.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/0001140361-18-044032-index.htm |
| 2018-09-30 | Keith J Kendall | CEO and President | Buy | 329.00 | 1,008,391.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118039945/0001140361-18-039945-index.htm | ||
| 2018-11-21 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 1,000.00 | 10.25 | 10,250.00 | 1,009,229.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043656/0001140361-18-043656-index.htm |
| 2018-12-06 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 2,000.00 | 8.69 | 17,380.00 | 1,018,624.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044870/0001140361-18-044870-index.htm |
| 2019-08-27 | Daniel Barber | SVP-Chief Operating Officer | Buy | 2,000.00 | 3.99 | 7,980.00 | 101,959.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005489/0001214659-19-005489-index.htm |
| 2018-12-10 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 1,000.00 | 7.78 | 7,780.00 | 1,019,624.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044950/0001140361-18-044950-index.htm |
| 2018-12-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 329.00 | 1,019,953.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036119000283/0001140361-19-000283-index.htm | ||
| 2020-04-29 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Sell | 40,000.00 | 4.50 | 180,000.00 | 1,022,113.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920003962/0001214659-20-003962-index.htm |
| 2018-11-30 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 1,023,801.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044536/0001140361-18-044536-index.htm | ||
| 2019-03-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 329.00 | 1,027,971.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919002419/0001214659-19-002419-index.htm | ||
| 2019-02-28 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 1,034,363.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001723/0001214659-19-001723-index.htm | ||
| 2019-06-30 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 329.00 | 1,036,018.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004458/0001214659-19-004458-index.htm | ||
| 2019-05-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 1,042,280.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919003980/0001214659-19-003980-index.htm | ||
| 2019-09-30 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 329.00 | 1,044,310.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919006188/0001214659-19-006188-index.htm | ||
| 2019-12-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 329.00 | 1,044,494.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920000041/0001214659-20-000041-index.htm | ||
| 2019-08-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 1,050,441.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005618/0001214659-19-005618-index.htm | ||
| 2019-11-30 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 1,058,737.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919007535/0001214659-19-007535-index.htm | ||
| 2020-03-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 329.00 | 1,062,210.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920003145/0001214659-20-003145-index.htm | ||
| 2020-02-29 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 1,066,947.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002184/0001214659-20-002184-index.htm | ||
| 2019-08-09 | LORI J BRAENDER | SVP, General Counsel | Buy | 10,000.00 | 4.07 | 40,747.00 | 11,000.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/0001214659-19-005183-index.htm |
| 2018-11-21 | Ken W. Marshall | Commercial Leader | Buy | 1,445.00 | 10.15 | 14,666.75 | 1,445.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044399/0001140361-18-044399-index.htm |
| 2018-11-21 | John T. Maxwell | SVP-Chief Financial Officer | Buy | 10,000.00 | 9.80 | 98,000.00 | 148,614.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/0001140361-18-043653-index.htm |
| 2020-08-18 | John T. Maxwell | SVP-Chief Financial Officer | Sell | 3,000.00 | 8.00 | 24,000.00 | 150,614.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/0001214659-20-007366-index.htm |
| 2018-12-06 | John T. Maxwell | SVP-Chief Financial Officer | Buy | 5,000.00 | 8.87 | 44,350.00 | 153,614.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/0001140361-18-044723-index.htm |
| 2019-08-19 | James S Scibetta | Director | Buy | 10,761.00 | 3.77 | 40,547.45 | 19,425.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm |
| 2020-03-16 | LORI J BRAENDER | SVP, General Counsel | Buy | 14,000.00 | 1.54 | 21,624.40 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/0001214659-20-002747-index.htm |
| 2019-08-20 | James S Scibetta | Director | Buy | 11,310.00 | 3.80 | 43,000.62 | 30,735.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm |
| 2019-08-21 | James S Scibetta | Director | Buy | 900.00 | 3.81 | 3,429.00 | 31,635.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm |
| 2018-11-21 | Peter E. Boyd | SVP-Operations/Value Delivery | Buy | 200.00 | 9.98 | 1,996.00 | 49,639.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043649/0001140361-18-043649-index.htm |
| 2019-08-12 | Peter E. Boyd | SVP-Bus. Process & Info. Tech. | Buy | 600.00 | 3.81 | 2,286.00 | 50,239.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005182/0001214659-19-005182-index.htm |
| 2020-03-16 | Peter E. Boyd | SVP-Bus. Process & Info. Tech. | Buy | 2,000.00 | 1.50 | 3,000.00 | 52,239.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002746/0001214659-20-002746-index.htm |
| 2018-11-21 | Keith J Kendall | CEO and President | Buy | 6,000.00 | 10.17 | 61,020.00 | 618,189.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm |
| 2018-11-23 | Keith J Kendall | CEO and President | Buy | 1,950.00 | 9.90 | 19,305.00 | 620,139.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm |
| 2018-11-27 | Keith J Kendall | CEO and President | Buy | 1,000.00 | 9.87 | 9,870.00 | 621,139.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043897/0001140361-18-043897-index.htm |
| 2018-12-31 | Keith J Kendall | CEO and President | Buy | 329.00 | 628,863.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036119000279/0001140361-19-000279-index.htm | ||
| 2018-11-30 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 635,711.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044533/0001140361-18-044533-index.htm | ||
| 2019-03-31 | Keith J Kendall | CEO and President | Buy | 329.00 | 638,877.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919002418/0001214659-19-002418-index.htm | ||
| 2020-06-04 | Keith J Kendall | CEO and President | Sell | 50,000.00 | 5.11 | 255,310.00 | 638,964.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005427/0001214659-20-005427-index.htm |
| 2020-06-30 | Keith J Kendall | CEO and President | Buy | 333.00 | 639,297.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920006104/0001214659-20-006104-index.htm | ||
| 2019-02-28 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 643,273.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919001724/0001214659-19-001724-index.htm | ||
| 2019-06-30 | Keith J Kendall | CEO and President | Buy | 329.00 | 646,735.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919004459/0001214659-19-004459-index.htm | ||
| 2019-08-09 | Keith J Kendall | CEO and President | Buy | 2,000.00 | 3.84 | 7,680.00 | 648,581.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-08-09 | Keith J Kendall | CEO and President | Buy | 1,000.00 | 3.93 | 3,925.00 | 649,581.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-08-09 | Keith J Kendall | CEO and President | Buy | 2,000.00 | 4.00 | 7,990.00 | 651,581.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-08-13 | Keith J Kendall | CEO and President | Buy | 1,000.00 | 4.05 | 4,045.00 | 652,581.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-05-31 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 653,186.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919003979/0001214659-19-003979-index.htm | ||
| 2019-08-14 | Keith J Kendall | CEO and President | Buy | 1,000.00 | 3.70 | 3,697.00 | 653,581.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-08-14 | Keith J Kendall | CEO and President | Buy | 1,000.00 | 3.65 | 3,650.00 | 654,581.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm |
| 2019-09-30 | Keith J Kendall | CEO and President | Buy | 329.00 | 662,806.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919006187/0001214659-19-006187-index.htm | ||
| 2019-12-31 | Keith J Kendall | CEO and President | Buy | 329.00 | 662,985.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920000018/0001214659-20-000018-index.htm | ||
| 2019-08-31 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 669,153.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005619/0001214659-19-005619-index.htm | ||
| 2019-11-30 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 677,228.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919007536/0001214659-19-007536-index.htm | ||
| 2020-03-31 | Keith J Kendall | CEO and President | Buy | 329.00 | 680,983.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920003146/0001214659-20-003146-index.htm | ||
| 2020-02-29 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 685,383.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920002183/0001214659-20-002183-index.htm | ||
| 2020-05-31 | Keith J Kendall | CEO and President | Buy | 14,572.00 | 695,456.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005338/0001214659-20-005338-index.htm | ||
| 2018-11-26 | Theresa Wood | SVP-HR and Org. Development | Buy | 500.00 | 10.34 | 5,170.00 | 79,765.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118043665/0001140361-18-043665-index.htm |
| 2019-08-09 | Theresa Wood | SVP-HR and Org. Development | Buy | 1,000.00 | 3.99 | 3,990.00 | 80,765.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465919005184/0001214659-19-005184-index.htm |
| 2020-05-08 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Sell | 40,000.00 | 5.00 | 200,000.00 | 902,113.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920004314/0001214659-20-004314-index.htm |
| 2020-06-30 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 333.00 | 912,886.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm | ||
| 2020-05-31 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Buy | 14,572.00 | 916,685.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920005339/0001214659-20-005339-index.htm | ||
| 2020-04-27 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Sell | 40,000.00 | 4.00 | 160,000.00 | 942,113.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm |
| 2020-04-14 | Alexander Mark Schobel | Chief Innovation/Tech Officer | Sell | 40,000.00 | 3.70 | 148,000.00 | 982,113.00 | https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm |
| 2018-12-10 | Daniel Barber | SVP-Chief Strategy/Dev Officer | Buy | 1,000.00 | 8.00 | 8,000.00 | 99,959.00 | https://www.sec.gov/Archives/edgar/data/1398733/000114036118044868/0001140361-18-044868-index.htm |